ReportWire

Tag: infections

  • Jamaica confirms infectious disease tied to Hurricane Melissa, puts public on alert

    [ad_1]

    TOPSHOT - Flooding and damaged buildings are seen in the aftermath of Hurricane Melissa in Lacovia, St Elizabeth, Jamaica, on October 31, 2025. At least 19 people in Jamaica have died as a result of Hurricane Melissa which devastated the island nation when it roared ashore this week, a government minister told news outlets late October 31. (Photo by Ricardo Makyn / AFP) (Photo by RICARDO MAKYN/AFP via Getty Images)

    Flooding and damaged buildings are seen in the aftermath of Hurricane Melissa in Lacovia, St Elizabeth, Jamaica, on October 31, 2025.

    AFP via Getty Images

    Jamaica is seeing an outbreak of leptospirosis and is urging anyone who is experiencing symptoms from the infectious disease to seek immediate medical care.

    A serious public health risk associated with heavy rainfalls, the disease is caused by the Leptospira bacteria found in water contaminated by the urine of infected animals like rats, cats, dogs and livestock. The signs of leptospirosis include flu-like symptoms with high fever, headache, chills and muscle aches. Infected persons can experience kidney or liver failure or internal bleeding.

    “It can affect anyone who comes in contact with contaminated soil or mud. That includes farmers, persons engaged in clean-up activities, emergency responders and others navigating flood areas,” Health Minister Christopher Tufton said.

    Tufton confirmed the outbreak on Friday. Health officials said there was in increase in confirmed and suspected cases across eight parishes in the aftermath of Hurricane Melissa, which devastated the island on Oct. 28 as a Category 5 hurricane. Preliminary assessments show that the country has suffered nearly $9 billion in damages.

    Tufton said there have been 28 probable cases of the infectious disease reported between Oct. 30 and Nov. 20.

    “The numbers reflect significantly more cases… than observed in the proceeding 34 months,” he said. “There have been six deaths from the suspected cases.”

    On Monday, the United Nations Development Program announced that it is providing an initial $2 million in grants to help stabilize affected communities, including restoring livelihoods of vulnerable groups and supporting national authorities and key sectors. An additional $8 million is also under consideration.

    More than 90 organizations are currently involved in Jamaica’s post-hurricane response, the U.N. said last week.

    “Response operations have been stepped up as access improves. Emergency medical teams and mobile clinics have now been deployed, allowing critical services to resume despite damaged infrastructure. Public health teams are also scaling up water-quality testing and environmental health inspections,” said Stéphane Dujarric, spokesman for U.N. Secretary-General António Guterres.

    More than 45,000 food kits have been distributed, while the World Food Program is working with the government to prepare a transition to cash-based assistance. Meanwhile, more than 100 emergency shelters remain open, but the effort is not without challenges.

    “Flooding is persisting, which is delaying the reopening of schools and further damaging agricultural roads and infrastructure,” Dujarric said. “The floods are also increasing risks to public health due to the risk of water-borne diseases,”

    Jacqueline Charles

    Miami Herald

    Jacqueline Charles has reported on Haiti and the English-speaking Caribbean for the Miami Herald for over a decade. A Pulitzer Prize finalist for her coverage of the 2010 Haiti earthquake, she was awarded a 2018 Maria Moors Cabot Prize — the most prestigious award for coverage of the Americas.

    [ad_2]

    Jacqueline Charles

    Source link

  • Virginia’s health department investigates another measles exposure at Dulles Airport – WTOP News

    [ad_1]

    The Virginia Department of Health has been notified of a confirmed case of measles at Dulles International Airport on Aug. 12.

    This article was republished with permission from WTOP’s news partner InsideNoVa.com. Sign up for InsideNoVa.com’s free email subscription today.

    The Virginia Department of Health has been notified of a confirmed case of measles at Dulles International Airport on Aug. 12.

    The patient is from another state, the VDH said in a Tuesday news release.

    Health officials are coordinating an effort to identify people who might have been exposed, including contacting potentially exposed passengers on specific flights.

    Listed below is the date, time and location of the potential exposure site:

    Dulles International Airport (IAD) on Tuesday, Aug. 12: in the main terminal, at the TSA security checkpoint, in Concourse B, and on transportation from the main terminal to Concourse B between 1 p.m. and 5 p.m.

    The potential exposure is one of several involving travelers through Virginia this year. The state has also seen three confirmed cases among Virginia residents.

    Measles is a highly contagious illness that can spread easily through the air when an infected person breathes, coughs, or sneezes, according to the VDH. Measles symptoms usually appear in two stages. In the first stage, most people have a fever of greater than 101 degrees, runny nose, watery red eyes, and a cough.

    The early symptoms usually start seven to 14 days after being exposed. The second stage starts three to five days after symptoms start, when a rash begins to appear on the face and spreads to the rest of the body. People with measles are contagious from four days before the rash appears through four days after the rash appeared.

    For the latest information on measles cases and exposures in Virginia, visit the VDH Measles website.

    To check your immunization status, call your healthcare provider or request your vaccination records using the VDH Immunization Record Request Form. Virginia residents with additional questions about their potential exposure can email epi_response@vdh.virginia.gov or contact your local health department.

    For more information about measles, visit www.vdh.virginia.gov/measles/.

    [ad_2]

    Will Vitka

    Source link

  • Someday, You Might Be Able to Eat Your Way Out of a Cold

    Someday, You Might Be Able to Eat Your Way Out of a Cold

    [ad_1]

    When it comes to treating disease with food, the quackery stretches back far. Through the centuries, raw garlic has been touted as a home treatment for everything from chlamydia to the common cold; Renaissance remedies for the plague included figs soaked in hyssop oil. During the 1918 flu pandemic, Americans wolfed down onions or chugged “fluid beef” gravy to keep the deadly virus at bay.

    Even in modern times, the internet abounds with dubious culinary cure-alls: apple-cider vinegar for gonorrhea; orange juice for malaria; mint, milk, and pineapple for tuberculosis. It all has a way of making real science sound like garbage. Research on nutrition and immunity “has been ruined a bit by all the writing out there on Eat this to cure cancer,” Lydia Lynch, an immunologist and a cancer biologist at Harvard, told me.

    In recent years, though, plenty of legit studies have confirmed that our diets really can affect our ability to fight off invaders—down to the fine-scale functioning of individual immune cells. Those studies belong to a new subfield of immunology sometimes referred to as immunometabolism. Researchers are still a long way off from being able to confidently recommend specific foods or dietary supplements for colds, flus, STIs, and other infectious illnesses. But someday, knowledge of how nutrients fuel the fight against disease could influence the way that infections are treated in hospitals, in clinics, and maybe at home—not just with antimicrobials and steroids but with dietary supplements, metabolic drugs, or whole foods.

    Although major breakthroughs in immunometabolism are just now arriving, the concepts that underlie them have been around for at least as long as the quackery. People have known for millennia that in the hours after we fall ill, our appetite dwindles; our body feels heavy and sluggish; we lose our thirst drive. In the 1980s, the veterinarian Benjamin Hart argued that those changes were a package deal—just some of many sickness behaviors, as he called them, that are evolutionarily hardwired into all sorts of creatures. The goal, Hart told me recently, is to “help the animal stay in one place and conserve energy”—especially as the body devotes a large proportion of its limited resources to igniting microbe-fighting fevers.

    The notion of illness-induced anorexia (not to be confused with the eating disorder anorexia nervosa) might seem, at first, like “a bit of a paradox,” says Zuri Sullivan, an immunologist at Harvard. Fighting pathogenic microbes is energetically costly—which makes eating less a very counterintuitive choice. But researchers have long posited that cutting down on calories could serve a strategic purpose: to deprive certain pathogens of essential nutrients. (Because viruses do not eat to acquire energy, this notion is limited to cell-based organisms such as bacteria, fungi, and parasites.) A team led by Miguel Soares, an immunologist at the Instituto Gulbenkian de Ciência, in Portugal, recently showed that this exact scenario might be playing out with malaria. As the parasites burst out of the red blood cells where they replicate, the resulting spray of heme (an oxygen-transporting molecule) prompts the liver to stop making glucose. The halt seems to deprive the parasites of nutrition, weakening them and tempering the infection’s worst effects.

    Cutting down on sugar can be a dangerous race to the bottom: Animals that forgo food while they’re sick are trying to starve out an invader before they themselves run out of energy. Let the glucose boycott stretch on too long, and the dieter might develop dangerously low blood sugar —a common complication of severe malaria—which can turn deadly if untreated. At the same time, though, a paucity of glucose might have beneficial effects on individual tissues and cells during certain immune fights. For example, low-carbohydrate, high-fat ketogenic diets seem to enhance the protective powers of certain types of immune cells in mice, making it tougher for particular pathogens to infiltrate airway tissue.

    Those findings are still far from potential human applications. But Andrew Wang, an immunologist and a rheumatologist at Yale, hopes that this sort of research could someday yield better clinical treatments for sepsis, an often fatal condition in which an infection spreads throughout the body, infiltrating the blood. “It’s still not understood exactly what you’re supposed to feed folks with sepsis,” Wang told me. He and his former mentor at Yale, Ruslan Medzhitov, are now running a clinical trial to see whether shifting the balance of carbohydrates and lipids in their diet speeds recovery for people ill with sepsis. If the team is able to suss out clear patterns, doctors might eventually be able to flip the body’s metabolic switches with carefully timed doses of drugs, giving immune cells a bigger edge against their enemies.

    But the rules of these food-illness interactions, to the extent that anyone understands them, are devilishly complex. Sepsis can be caused by a whole slew of different pathogens. And context really, really matters. In 2016, Wang, Medzhitov, and their colleagues discovered that feeding mice glucose during infections created starkly different effects depending on the nature of the pathogen driving disease. When the mice were pumped full of glucose while infected with the bacterium Listeria, all of them died—whereas about half of the rodents that were allowed to give in to their infection-induced anorexia lived. Meanwhile, the same sugary menu increased survival rates for mice with the flu.

    In this case, the difference doesn’t seem to boil down to what the microbe was eating. Instead, the mice’s diet changed the nature of the immune response they were able to marshal—and how much collateral damage that response was able to inflict on the body, as James Hamblin wrote for The Atlantic at the time. The type of inflammation that mice ignited against Listeria, the team found, could imperil fragile brain cells when the rodents were well fed. But when the mice went off sugar, their starved livers started producing an alternate fuel source called ketone bodies—the same compounds people make when on a ketogenic diet—that helped steel their neurons. Even as the mice fought off their bacterial infections, their brain stayed resilient to the inflammatory burn. The opposite played out when the researchers subbed in influenza, a virus that sparks a different type of inflammation: Glucose pushed brain cells into better shielding themselves against the immune system’s fiery response.

    There’s not yet one unifying principle to explain these differences. But they are a reminder of an underappreciated aspect of immunity. Surviving disease, after all, isn’t just about purging a pathogen from the body; our tissues also have to guard themselves from shrapnel as immune cells and microbes wage all-out war. It’s now becoming clear, Soares told me, that “metabolic reprogramming is a big component of that protection.” The tactics that thwart a bacterium like Listeria might not also shield us from a virus, a parasite, or a fungus; they may not be ideal during peacetime. Which means our bodies must constantly toggle between metabolic states.

    In the same way that the types of infections likely matter, so do the specific types of nutrients: animal fats, plant fats, starches, simple sugars, proteins. Like glucose, fats can be boons in some contexts but detrimental in others, as Lynch has found. In people with obesity or other metabolic conditions, immune cells appear to reconfigure themselves to rely more heavily on fats as they perform their day-to-day functions. They can also be more sluggish when they attack. That’s the case for a class of cells called natural killers: “They still recognize cancer or a virally infected cell and go to it as something that needs to be killed,” Lynch told me. “But they lack the energy to actually kill it.” Timing, too, almost certainly has an effect. The immune defenses that help someone expunge a virus in the first few days of an infection might not be the ones that are ideal later on in the course of disease.

    Even starving out bacterial enemies isn’t a surefire strategy. A few years ago, Janelle Ayres, an immunologist at the Salk Institute for Biological Studies, and her colleagues found that when they infected mice with Salmonella and didn’t allow the rodents to eat, the hungry microbes in their guts began to spread outside of the intestines, likely in search of food. The migration ended up killing tons of their tiny mammal hosts. Mice that ate normally, meanwhile, fared far better—though the Salmonella inside of them also had an easier time transmitting to new hosts. The microbes, too, were responding to the metabolic milieu, and trying to adapt. “It would be great if it was as simple as ‘If you have a bacterial infection, reduce glucose,’” Ayres said. “But I think we just don’t know.”

    All of this leaves immunometabolism in a somewhat chaotic state. “We don’t have simple recommendations” on how to eat your way to better immunity, Medzhitov told me. And any that eventually emerge will likely have to be tempered by caveats: Factors such as age, sex, infection and vaccination history, underlying medical conditions, and more can all alter people’s immunometabolic needs. After Medzhitov’s 2016 study on glucose and viral infections was published, he recalls being dismayed by a piece from a foreign outlet circulating online claiming that “a scientist from the USA says that during flu, you should eat candy,” he told me with a sigh. “That was bad.”

    But considering how chaotic, individualistic, and messy nutrition is for humans, it shouldn’t be a surprise that the dietary principles governing our individual cells can get pretty complicated too. For now, Medzhitov said, we may be able to follow our instincts. Our bodies, after all, have been navigating this mess for millennia, and have probably picked up some sense of what they need along the way. It may not be a coincidence that during viral infections, “something sweet like honey and tea can really feel good,” Medzhitov said. There may even be some immunological value in downing the sick-day classic, chicken soup: It’s chock-full of fluid and salts, helpful things to ingest when the body’s electrolyte balance has been thrown out of whack by disease.

    The science around sickness cravings is far from settled. Still, Sullivan, who trained with Medzhitov, jokes that she now feels better about indulging in Talenti mango sorbet when she’s feeling under the weather with something viral, thanks to her colleagues’ 2016 finds. Maybe the sugar helps her body battle the virus without harming itself; then again, maybe not. For now, she figures it can’t hurt to dig in.

    [ad_2]

    Katherine J. Wu

    Source link

  • How Worried Should We Be About XBB.1.5?

    How Worried Should We Be About XBB.1.5?

    [ad_1]

    After months and months of SARS-CoV-2 subvariant soup, one ingredient has emerged in the United States with a flavor pungent enough to overwhelm the rest: XBB.1.5, an Omicron offshoot that now accounts for an estimated 75 percent of cases in the Northeast. A crafty dodger of antibodies that is able to grip extra tightly onto the surface of our cells, XBB.1.5 is now officially the country’s fastest-spreading coronavirus subvariant. In the last week of December alone, it zoomed from 20 percent of estimated infections nationwide to 40 percent; soon, it’s expected to be all that’s left, or at least very close. “That’s the big thing everybody looks for—how quickly it takes over from existing variants,” says Shaun Truelove, an infectious-disease modeler at Johns Hopkins University. “And that’s a really quick rise.”

    All of this raises familiar worries: more illness, more long COVID, more hospitalizations, more health-care system strain. With holiday cheer and chilly temperatures crowding people indoors, and the uptake of bivalent vaccines at an abysmal low, a winter wave was already brewing in the U.S. The impending dominance of an especially speedy, immune-evasive variant, Truelove told me, could ratchet up that swell.

    But the American public has heard that warning many, many, many times before—and by and large, the situation has not changed. The world has come a long way since early 2020, when it lacked vaccines and drugs to combat the coronavirus; now, with immunity from shots and past infections slathered across the planet—porous and uneven though that layer may be—the population is no longer nearly so vulnerable to COVID’s worst effects. Nor is XBB.1.5 a doomsday-caliber threat. So far, no evidence suggests that the subvariant is inherently more severe than its predecessors. When its close sibling, XBB, swamped Singapore a few months ago, pushing case counts up, hospitalizations didn’t undergo a disproportionately massive spike (though XBB.1.5 is more transmissible, and the U.S. is less well vaccinated). Compared with the original Omicron surge that pummeled the nation this time last year, “I think there’s less to be worried about,” especially for people who are up to date on their vaccines, says Mehul Suthar, a viral immunologist at Emory University who’s been studying how the immune system reacts to new variants. “My previous exposures are probably going to help against any XBB infection I have.”

    SARS-CoV-2’s evolution is still worth tracking closely through genomic surveillance—which is only getting harder as testing efforts continue to be pared back. But “variants mean something a little different now for most of the world than they did earlier in the pandemic,” says Emma Hodcroft, a molecular epidemiologist at the University of Bern, in Switzerland, who’s been tracking the proportions of SARS-Cov-2 variants around the world. Versions of the virus that can elude a subset of our immune defenses are, after all, going to keep on coming, for as long as SARS-CoV-2 is with us—likely forever, as my colleague Sarah Zhang has written. It’s the classic host-pathogen arms race: Viruses infect us; our bodies, hoping to avoid a similarly severe reinfection, build up defenses, goading the invader into modifying its features so it can infiltrate us anew.

    But the virus is not evolving toward the point where it’s unstoppable; it’s only switching up its fencing stance to sidestep our latest parries as we do the same for it. A version of the virus that succeeds in one place may flop in another, depending on the context: local vaccination and infection histories, for instance, or how many elderly and immunocompromised individuals are around, and the degree to which everyone avoids trading public air. With the world’s immune landscape now so uneven, “it’s getting harder for the virus to do that synchronized wave that Omicron did this time last year,” says Verity Hill, an evolutionary virologist at Yale. It will keep trying to creep around our defenses, says Pavitra Roychoudhury, who’s monitoring SARS-CoV-2 variants at the University of Washington, but “I don’t think we need to have alarm-bell emojis for every variant that comes out.”

    Some particularly worrying variants and subvariants will continue to arise, with telltale signs, Roychoudhury told me: a steep increase in wastewater surveillance, followed by a catastrophic climb in hospitalizations; a superfast takeover that kicks other coronavirus strains off the stage in a matter of days or weeks. Omens such as these hint at a variant that’s probably so good at circumventing existing immune defenses that it will easily sicken just about everyone again—and cause enough illness overall that a large number of cases turn severe. Also possible is a future variant that is inherently more virulent, adding risk to every new case. In extreme versions of these scenarios, tests, treatments, and masks might need to come back into mass use; researchers may need to concoct a new vaccine recipe  at an accelerated pace. But that’s a threshold that most variations of SARS-CoV-2 will not clear—including, it seems so far, XBB.1.5. Right now, Hodcroft told me, “it’s hard to imagine that anything we’ve been seeing in the last few months would really cause a rush to do a vaccine update,” or anything else similarly extreme. “We don’t make a new flu vaccine every time we see a new variant, and we see those all through the year.” Our current crop of BA.5-focused shots is not a great match for XBB.1.5, as Suthar and his colleagues have found, at least on the antibody front. But antibodies aren’t the only defenses at play—and Suthar told me it’s still far better to have the new vaccine than not.

    In the U.S., wastewater counts and hospitalizations are ticking upward, and XBB.1.5 is quickly elbowing out its peers. But the estimated infection rise doesn’t seem nearly as steep as the ascension of the original Omicron variant, BA.1 (though our tracking is now poorer). XBB.1.5 also isn’t dominating equally in different parts of the country—and Truelove points out that it doesn’t yet seem tightly linked to hospitalizations in the places where it’s gained traction so far. As tempting as it may be to blame any rise in cases and hospitalizations on the latest subvariant, our own behaviors are at least as important. Drop-offs in vaccine uptake or big jumps in mitigation-free mingling can drive spikes in illness on their own. “We were expecting a wave already, this time of year,” Hill told me. Travel is up, masking is down. And just 15 percent of Americans over the age of 5 have received a bivalent shot.

    The pace at which new SARS-CoV-2 variants and subvariants take over could eventually slow, but the experts I spoke with weren’t sure this would happen. Immunity across the globe remains patchy; only a subset of countries have access to updated bivalent vaccines, while some countries are still struggling to get first doses into millions of arms. And with nearly all COVID-dampening mitigations “pretty much gone” on a global scale, Hodcroft told me, it’s gotten awfully easy for the coronavirus to keep experimenting with new ways to stump our immune defenses. XBB.1.5 is both the product and the catalyst of unfettered spread—and should that continue, the virus will take advantage again.

    [ad_2]

    Katherine J. Wu

    Source link

  • Annual COVID Shots Mean We Can Stop Counting

    Annual COVID Shots Mean We Can Stop Counting

    [ad_1]

    A couple of weeks ago, a friend asked me how many COVID shots I’d gotten so far. And for a brief, wonderful moment, I forgot.

    “Three,” I told them, before shaking my head. “No, actually, four.” I had no trouble recalling when I’d received my most recent shot (September). But it took me a moment to tabulate all the doses that had preceded it.

    By this point in the pandemic, a lot of people must be losing track. “I actually think this is a good thing,” says Grace Lee, a pediatrician at Stanford, and the chair of the CDC’s Advisory Committee on Immunization Practices. Now that so many Americans have racked up several shots or infections, she told me, the question is no longer “‘How many doses have you gotten cumulatively?’ It’s ‘Are you up to date for the season?’”

    The flip is subtle, but it marks a rethink of the COVID-vaccination paradigm. We’re at a define-the-relationship moment with these shots, when people are trying to commit—to normalize them as a routine part of our lives. At a September ACIP meeting, CDC officials noted that “we are changing the way we are thinking about these vaccines,” and trying to “get on a more regular schedule.” If COVID shots are here for good, then at least we can be rid of the bother of counting them.

    Counting doses was more apt early in the vaccine rollout, when it seemed that two jabs (or even one) would be enough to get Americans “fully vaccinated” and out of the danger zone. When more shots followed, they were often advertised with confusing finality: What some initially described as the booster was later retconned as the first booster after a second one was recommended for certain groups. But with immunity against infection more fragile than some hoped, and a virus that quickly shapeshifts out of antibodies’ grasp, those ordinal adjectives have stopped making sense. Until our vaccine tech becomes much more durable or variant-proof, repeat doses will be, for most of us, a fixture of the future—and it won’t do anyone much good to say, “‘I’m on shot 15’ or ‘I’m on shot 16,’” Angela Shen, a vaccine expert at Children’s Hospital of Philadelphia, told me.

    The numbers certainly matter when they’re small: It will continue to be important for people to count off their first few shots, for instance, especially those without a history of infections. But after that initial set of viral-spike-protein exposures, the total count is moot. In most cases, about three vaccinations or infections—preferably vaccinations, which are both safer and easier to accurately track—should be “enough to fully charge up the immune system’s battery” for the first time, says Rishi Goel, an immunologist at the University of Pennsylvania. Further COVID shots will help only insofar as they can recharge the battery toward max capacity when it starts to lose its juice. Scheduling a vaccine, then, becomes a matter of “how long it’s been since your last immunity-conferring event,” regardless of how many exposures a body has racked up, says Avnika Amin, a vaccine epidemiologist at Emory University.

    People who are immunocompromised may need four or more shots to establish that initial immunity charge, and their own (maybe smaller) peak capacity. But ultimately, the threshold effect they experience—a point of “diminishing returns”—is similar, says Marion Pepper, an immunologist at the University of Washington. Given how many vaccinations and infections the U.S. has now logged, the majority of Americans “can be done with counting,” she told me.


    If we’re going to shift our focus to timing shots, instead of counting them, we’ll have to schedule our shots smartly. Several prominent figures have already come out and said that yearly doses are a top choice. Albert Bourla, Pfizer’s CEO, has been pushing that idea since early 2021; Peter Marks, who heads the FDA’s Center for Biologics Evaluation and Research, has been delivering a similar line for several months. Even President Joe Biden has endorsed the annual approach, noting in a September statement that the debut of the bivalent shot heralded a new phase in COVID vaccination, in which Americans would receive a dose “once a year, each fall.”

    That plan is not unreasonable. Shots will have to come with at least some regularity, as variants keep rolling in and immunity against infection ebbs. But re-dose prematurely with a shot with similar ingredients, and the body—still hopped up from the previous dose—may destroy the vaccine before it has much effect, making it about as useful as charging a battery that’s already at 95 percent. SARS-CoV-2 antibody levels drop off steeply in the first six months following a vaccine dose, and then, the rate of drain slows down. It’s as if the immune system goes into “power-saver mode,” Goel told me, which means there might not be a huge difference between revaccinating twice a year or only once. Plus, living out much of the year with lower antibody levels is not as worrisome as it might sound. Although antibodies can be a rather useful proxy for our level of protection, especially against infection, they don’t paint the whole defensive picture: T cells and other fighters tend to stick around for far longer, maintaining safeguards against severe disease. (The immunocompromised and older people may still need more frequent COVID-immunity top-offs.)

    The optimal pace for COVID vaccination will also depend on the speed at which the virus spews out variants. A yearly schedule works for influenza, Shen told me, but “we know flu’s cadence.” SARS-CoV-2 hasn’t yet settled down into a predictable, seasonal pattern; its waves aren’t relegated to the chilliest months. The degree to which we, as the coronavirus’s hosts, tamp down transmission also matters quite a bit. Having more virus around puts more pressure on vaccines to perform, especially when there aren’t many other mitigation measures in place. If all this talk of “once a year, each fall” turns out to be another red-herring recommendation, Amin told me, it could undermine any messaging that follows.

    All of that said, the autumn regimen may yet stick around because it’s the easiest approach. Flu-shot uptake is far from perfect, but the messaging around it is “simple and clean,” says Rupali Limaye, a behavioral scientist and vaccine-attitudes researcher at Johns Hopkins. After dosing up twice in four weeks as infants, people are asked to get a yearly shot, and that’s it. Compare that with the most convoluted days of COVID vaccination, when people couldn’t dose up without accounting for their age, health status, number of previous doses, vaccine brand, time since last dose, and more. “That’s absolute overload,” Limaye told me. Complicated schedules burn people out—or dissuade them from showing up at all. This fall, when the bivalent shot debuted, a troubling proportion of Americans didn’t even know they were eligible.

    Encouraging COVID vaccines at the same, straightforward pace as flu shots would make it easy for people to sign up for both at once, and maybe, eventually, to get them in the same syringe. Vaccines tend to ride one another’s coattails, Shen told me. “In the fall, there’s a bump in other routine vaccines,” she said, because people “are already there for their flu shot.” It would also make a big difference if the COVID-vaccine recipes changed for everyone at the same time, as they do for flu.

    If we’re going to pivot from numbering doses to timing them, we might as well take the opportunity to discard the term booster as well. Some people don’t understand what it means, Limaye told me, or they default to a logical question—How many more boosters will I need? Plus, booster may no longer fit the science. “When we start updating formulas, it’s not really a booster anymore,” Amin told me. That’s not how we generally talk about flu shots: I certainly couldn’t tell you how many “boosters” of that vaccine I’ve had. (I don’t know, maybe 14? 15?) Pivoting to a terminology of “seasonal shots” could make COVID vaccination that much more routine.

    So, fine, if anyone should ask: I’ve had (count ’em: one, two, three) four doses of the vaccine so far. But more important, I’ve gotten the shot most recently available to me.

    [ad_2]

    Katherine J. Wu

    Source link

  • How to Handle an STI That Shows Up on Your Face

    How to Handle an STI That Shows Up on Your Face

    [ad_1]

    Concerned About a Facial STI That’s Drawing Too Much Attention? Do This

    Product photos from retailer sites.


    No one actively tries to get a STD (or as they’re more commonly referred to these days, STIs). While you likely have a general idea of how not to get yourself infected with one, knowing the nuances of how each type of STI gets contracted and the respective prevention/treatment methods are key to not only keeping yourself from getting one, but from spreading it to your next partner.

    Take, for example, syphilis. There was a time when this particular STI was basically on the path toward being eliminated. Then in the early 2000s, it started to rear its ugly head again, bringing the stats of men affected by syphilis in the U.S. from every 2.9 per 100,000 people in 2005 to every 5.3 per 100,000 in 2013, all the way up to 8.7 per 100,000 people in 2016, according to the CDC.

    RELATEDEverything You Need to Know About Getting Tested for STIs

    Sure, talking with your partner about sexually transmitted infections isn’t pleasant, but neither is contracting one … especially when it shows up on your face. To save face later on, you’ll want to know what STIs you’re at risk for, ways to detect the signs in order to seek proper treatment and most importantly, how they get spread so that you can avoid doing so. Below, you’ll find out all of those important details.


    Different STIs and How to Deal With Them


    Syphilis

    Let’s start with the STI that’s been taking the U.S. by storm as of late. Syphilis is a bacterial infection that spreads throughout the body and, if not treated, can impact all of your organ systems. Yes, all of them.

    “Primary syphilis is an [STI] caused by the spirochete bacterium Treponema pallidum,” explains dermatologist Tsippora Shainhouse, MD, FAAD. Once a person has syphilis, an ulcer will soon form. “It will present 10-90 days (average 21 days) after exposure, last 2-6 weeks, before resolving spontaneously,” she adds. “The problem is that if it wasn’t treated with antibiotics (penicillin injection is most effective), it isn’t really gone — and you will end up with secondary syphilis within 3-10 weeks of the ulcer resolution.”

    If it gets left untreated, Shainhouse says this disease can resurface as what’s known as tertiary syphilis years later, affecting vital organs like the heart or brain.

    How It’s Spread

    Making contact with a syphilis ulcer causes the disease to spread. “Syphilis is transmitted person to person via direct contact with a syphilis ulcer during vaginal, anal or oral sex and may enter through skin or mucous membranes,” says Shainhouse. “Hence, the locations for syphilitic ulcers include the vagina, cervix, penis, anus, rectum, lips, hands and inside of the mouth.”  

    How It Shows Up on Your Face

    “Both primary and secondary syphilis symptoms can present on the face,” explains Dr. Samuel Malloy, general practitioner at Dr. Felix. “The sores of primary syphilis are most likely to appear on the face if you have had oral sex with a syphilis-infected person. This is because the sores usually occur at the site of the infection. But secondary syphilis symptoms can appear on the face from other forms of sexual contact and congenital syphilis as the syphilis has entered the body, and the rash is the body’s response to the infection.”  

    How to Prevent It

    As you may have guessed, condoms are key for keeping syphilis at bay. “Use a condom if having vaginal or anal sex,” says Malloy. “Syphilis is increasing amongst men who have sex with men, so it’s important to use a condom — even if there is no risk of pregnancy. You can also use a dental dam to protect against contracting syphilis orally.”

    How to Treat It

    “Syphilis can usually be treated by a course of antibiotics prescribed by your doctor,” notes Malloy, with a dose of penicillin being the typical course of action. “However, not all symptoms of syphilis are reversible,” Malloy continues. “The sores/rashes can cause scarring, and the symptoms of tertiary syphilis may be irreversible.”

    Genital Herpes

    Genital herpes is a viral infection caused by the Herpes Simplex Virus, Type 1 or Type 2,” explains Malloy. “HSV 1 is the virus usually responsible for oral herpes, but this can cause sores in the genital area. HSV 2 is the virus usually responsible for genital herpes, but can also cause sores on the face.”

    How It’s Spread

    “Genital herpes is spread through contact with others who also are infected with herpes,” says Malloy. “This contact usually happens through oral, anal or vaginal sexual activity, but can also occur through kissing.” If getting this STI just by swapping spit has you stressed about offering your date a sip of your drink, fear not. “Genital herpes is not spread by sharing drinking glasses or towels, etc. as the virus cannot survive long outside the body,” he adds.

    How It Shows Up on Your Face

    “The location of the herpes sores are usually related to the site of the infection,” explains Malloy. “However, once infected with the herpes virus, you will usually experience several outbreaks. These outbreaks may cause sores in different areas and you can spread the infection to different areas of your body through touching the sores and then other areas.” If you’re experiencing an outbreak, it’s best to wash your hands after coming in contact with the sores to keep it from spreading to other regions of your body.

    How to Treat It

    In case you didn’t already know, herpes is an STI that stays with you forever — though it can lay dormant in your system with the effects in a constant ebb and flow. However, there are treatment options for the symptoms, as well as ways to prevent future outbreaks. 

    RELATED: How to Prevent and Treat Cold Sores

    “When you first experience symptoms, you may be prescribed antiviral tablets to prevent the infection from progressing,” says Malloy. “You may also be given a cream to alleviate the pain. If you have regular outbreaks, your doctor may prescribe you Aciclovir or Valaciclovir to reduce the likelihood of further outbreaks.” There are also things you can do to make yourself more comfortable during an outbreak, from wearing loose clothing to applying ice to the affected area.

    How to Prevent It

    Although herpes can only be spread when there are visible sores, it’s important to note that once they begin to bud, they’re very easily spread — even before they’re extremely prominent. “The virus is highly contagious, from the first tingle of a new sore until it has completely healed,” warns Malloy. “If your partner has any sores, you should either avoid contact with the affected area until the outbreak has resolved, or you should use a condom and/or dental dam to prevent contact with the affected area. If these methods do not cover the sore, there is a risk you could also contract the virus.”

    RELATED: The Best And Most Reliable At-Home STI Kits

    Chlamydia

    The stats on chlamydia are staggering with an estimated two million Americans affected by this disease. One of the reasons why chlamydia is so easily spread is the fact that this bacterial infection is often symptomless. Chlamydia is more common in women, but 70-80 percent of females diagnosed don’t show symptoms.

    “Chlamydia is an infection by a bacteria known as chlamydia trachomatis (if you want to get scientific),” says Dr. James Wantuck, MD of PlushCare. “It most commonly infects the genitals of women and men, and it is sexually transmitted.” It spreads by targeting the mucous membranes, which lines the internal organs that don’t have the luxury of being protected by the skin including the vagina, rectum, cervix and urethra.  

    How It’s Spread

    Because of the membranes this disease targets, it gets spread thanks to fluid transfers that happen during sex. “Chlamydia is not spread by skin-to-skin contact, but instead by contact with the sexual fluids of an infected person,” explains Malloy. “Sexual fluids include semen or vaginal fluids, and chlamydia can be spread through anal, vaginal or oral sex.”

    How It Shows Up on Your Face

    Not-so-fun fact: Chlamydia can actually end up causing pink eye. “Chlamydia can affect the eyes, which usually happens if any sexual fluids enter the eye, either through ejaculation, or if you have some fluids on your hand and then you touch the eye,” notes Malloy. “This can cause conjunctivitis, also known as pink eye. If you have contracted chlamydia through oral sex, you may experience chlamydia symptoms in and around the mouth.”

    How to Treat It

    “Chlamydia is treated by a course of antibiotics, such as azithromycin or doxycycline,” says Malloy. This is definitely one time where you’ll want to make sure you finish the entire duration of your medication, and follow the directions to the letter. “If you are given antibiotics, it is important to follow your doctor’s instructions exactly to prevent antibiotic resistance,” he adds.

    How to Prevent It

    The tough part about preventing chlamydia is the fact that it’s so symptomless. As long as you’re being diligent about safe sex practices, you should be in the clear. “Chlamydia can be prevented by using dental dams or condoms during sex, and taking care to avoid contact with infected sexual fluids,” says Malloy.


    Recommended Products for STIs on Your Face


    Though you should probably check with your doctor before adding any sort of medicine or cream to your treatment routine, there are some products available online that could make a difference in your level of pain. From clearing your eyes to healing your skin, try these recommended choices:

    Pink Eye Relief Drops

    Since some STIs show up not only on your face, but in your eyes (ouch!), you could have symptoms that mimic pink eye. You will need a prescription, sure, but these drops can also make any pain or discoloration more bearable. Free of chemicals, a few uses of these bad boys will fight against redness, swelling, itching and more.
    $13.98 at Amazon.com

    Wart Removal Cream

    Wart Removal Cream and cream

    Some of the physical bumps that show up thanks to STIs look much like the warts you could have suffered from as a child. This ointment cream works to make these less painful, smaller and more manageable. Check with your dermatologist or doctor before overdoing it, but this is great to keep on hand for breakouts.
    $34.95 at Amazon.com

    After Shave Balm

    Dove Men After Shave Balm

    (Not so) fun fact: Even if you have an STI-induced reaction, the hair on your face will still grow. And that means you’ll need to shave, too. This could make razor burn that’s much more intense, making this balm your best buddy. Apply religiously when you freshen up to experience less stinging or discomfort.
    $12.99 at Amazon.com

    You Might Also Dig

    [ad_2]

    Danielle Page

    Source link